HS
GSK icon

HighVista Strategies’s GSK GSK Stock Holding History

HighVista Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-37,218
Closed -$1.89M – 181
2016
Q1 		$1.89M Buy
37,218
+3,600
+11% +$179K 0.35% 67
2015
Q4 		$1.7M Buy
33,618
+340
+1% +$17.3K 0.32% 72
2015
Q3 		$1.6M Buy
+33,278
New +$1.73M 0.3% 97
2014
Q4 		– Sell
-32,885
Closed -$1.89M – 168
2014
Q3 		$1.89M Buy
32,885
+556
+2% +$34.1K 0.25% 87
2014
Q2 		$2.16M Sell
32,329
-564
-2% -$38.2K 0.31% 80
2014
Q1 		$2.26M Buy
+32,893
New +$2.22M 0.3% 84

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

HighVista Strategies's GSK Position: Q2 2016 in Review

HighVista Strategies sold out of GSK (GSK) in Q2 2016, closing a stake of 37,218 shares — an estimated $1.89M sold.

HighVista Strategies first reported a position in GSK in Q1 2014 and held it in 6 quarters. The position peaked at $2.26M in Q1 2014. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • HighVista Strategies reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
  • HighVista Strategies sold 37,218 GSK shares in Q2 2016, an estimated $1.89M.
  • HighVista Strategies first reported a position in GSK in Q1 2014 and held it in 6 quarters.
  • HighVista Strategies's GSK position peaked at $2.26M in Q1 2014.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on HighVista Strategies's 13F filing for Q2 2016, filed 15 Aug 2016.